Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA‑126: A new and promising player in lung cancer (Review)
Qijun Chen, Shuanghua Chen, Juanjuan Zhao, et al.
Oncology Letters (2020) Vol. 21, Iss. 1, pp. 1-1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Exosomal microRNAs in regulation of tumor cells resistance to apoptosis
Mohammad Salehi, Mohammad Javad Kamali, Daniyal Arab, et al.
Biochemistry and Biophysics Reports (2024) Vol. 37, pp. 101644-101644
Open Access | Times Cited: 15
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Anna Valeria Samarelli, Valentina Masciale, Beatrice Aramini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12179-12179
Open Access | Times Cited: 62
Mitochondrial miRNAs (MitomiRs): Their potential roles in breast and other cancers
Elif Ertürk, Omer Enes Onur, Oğuzhan Akgün, et al.
Mitochondrion (2022) Vol. 66, pp. 74-81
Closed Access | Times Cited: 58
Coxsackievirus B3—Its Potential as an Oncolytic Virus
Anja Geisler, Ahmet Hazini, Lisanne Heimann, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 718-718
Open Access | Times Cited: 34
miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
Kousain Kousar, Tahir Ahmad, Maisa Siddiq Abduh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13822-13822
Open Access | Times Cited: 25
Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer
Osama Sweef, Elsayed Zaabout, Ahmed Bakheet, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2061-2061
Open Access | Times Cited: 14
Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease
Riya Thapa, Arockia Babu Marianesan, Arcot Rekha, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Open Access
Enigmatic exosomal connection in lung cancer drug resistance
Sambit K. Patra, Rajeev Kumar Sahoo, Stuti Biswal, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102177-102177
Open Access | Times Cited: 4
Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands
Sarah S. Hassanein, Sherif Ibrahim, Ahmed Abdel-Mawgood
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12496-12496
Open Access | Times Cited: 26
LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma
Yudong Wang, Xingke Mei, Weikang Song, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection
Ray Bahado‐Singh, Kyriacos T. Vlachos, Buket Aydas, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
Jolanta Smok-Kalwat, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1506-1506
Open Access | Times Cited: 10
Tumor-derived lncRNAs: Behind-the-scenes mediators that modulate the immune system and play a role in cancer pathogenesis
Sulieman Ibraheem Shelash Al-Hawary, Raed Obaid Saleh, Sada Gh. Taher, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155123-155123
Closed Access | Times Cited: 3
Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm
Anahita Beigi, Seyed Morteza Naghib, Amir Matini, et al.
Current Gene Therapy (2024) Vol. 25, Iss. 2, pp. 92-112
Closed Access | Times Cited: 3
Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer
Wenchang Lv, Yufang Tan, Xiaomei Zhou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Long non‑coding RNA SLC25A25‑AS1 exhibits oncogenic roles in non‑small cell lung cancer by regulating the microRNA‑195‑5p/ITGA2 axis
Jinqin Chen, Chengpeng Gao, Wei Zhu
Oncology Letters (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 18
MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?
Anna Grenda, Barbara Kuźnar-Kamińska, Ewa Kalinka‐Warzocha, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Systems Biology and Machine Learning Identify Genetic Overlaps Between Lung Cancer and Gastroesophageal Reflux Disease
Sanjukta Dasgupta
OMICS A Journal of Integrative Biology (2024)
Closed Access | Times Cited: 2
Involvement of microRNA in Solid Cancer: Role and Regulatory Mechanisms
Ying‐Chin Lin, Tso-Hsiao Chen, Yu‐Min Huang, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 343-343
Open Access | Times Cited: 17
Pro-angiogenic approach for skeletal muscle regeneration
Juliana Ferreira Floriano, Costanza Emanueli, Sofía Vega, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1866, Iss. 2, pp. 130059-130059
Open Access | Times Cited: 17
Role of microRNAs in Lung Carcinogenesis Induced by Asbestos
R. I. Bersimbaev, Olga Bulgakova, Akmaral Aripova, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 97-97
Open Access | Times Cited: 14
MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives
Marta Wielogórska, Beata Podgórska, Magdalena Niemira, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 876-876
Open Access | Times Cited: 9
MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
Behnaz Lahooti, Sagun Poudel, Constantinos M. Mikelis, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Construction of a four-mRNA prognostic signature with its ceRNA network in CESC
Lang Li, Qiusheng Guo, Gaochen Lan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Remote Adipose Tissue-Derived Stromal Cells of Patients with Lung Adenocarcinoma Generate a Similar Malignant Microenvironment of the Lung Stromal Counterpart
Elena De Falco, Antonella Bordin, Cecilia Menna, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top